Literature DB >> 1596893

Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells.

H J Gruss1, M A Brach, H G Drexler, R Bonifer, R H Mertelsmann, F Herrmann.   

Abstract

In the present study, we show by Northern blot analysis and enzyme linked immunosorbent assay that the Hodgkin's disease (HD)-derived cell lines HDLM-2 and KM-H2 express a variety of cytokine genes either constitutively or upon induction with phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Cytokine genes expressed by HD-derived lines include granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, interleukin (IL)-1-alpha, IL-3, IL-5, IL-6, IL-8, leukemia inhibitory factor, tumor necrosis factor-alpha, tumor necrosis factor-beta, and transforming growth factor-beta, while transcripts and the corresponding proteins for granulocyte-CSF, IL-1-beta, IL-2, IL-4, IL-7, IL-10, and the JE/macrophage chemoattractant and activating factor gene were not detectable in cytoplasmic RNA and culture supernatants obtained from both lines. In addition, IL-2 receptor (R) p55 and macrophage-CSF R (c-fms) genes were expressed by both lines. HDLM-2, but not KM-H2 cells, exhibited the IL-6 R p80 and the IL-2 R p75 chain. Analysis of nuclear proteins that bind to oligonucleotides containing the consensus sequences of the transcription factors activation protein 1, nuclear factor (NF) kappa B, and NFAT 1 revealed a pattern for HD lines resembling that of activated T-cells: HDLM-2 and KM-H2 cells constitutively expressed NF binding to the NF of activated T-cells (type 1), previously described to be T-cell specific. In addition, NF kappa B-binding proteins obtained from both lines showed, in electrophoretic mobility shift assays, the same migration pattern as T-cell-derived proteins but differed from monocyte- and B-cell-derived proteins. UV cross-linking experiments confirmed that NF kappa B-binding proteins of M(r) 85,000, 75,000, and 50,000/55,000 were detectable in nuclear extracts obtained from T-cells and both HD lines, while monocytes and B-cells displayed the M(r) 50,000/55,000 and 75,000 NF kappa B complex only. Both HD lines also constitutively expressed transcripts for c-fos and c-jun, which are involved in heterodimeric formation of the transcription factor activation protein 1, as well as for the NF kappa B/KBF1 gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596893

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Luteinizing hormone pulsatility and computer-assisted analysis of sperm features in patients with Hodgkin's disease.

Authors:  M Magnanti; S Malizia; G Garufi; A Lenzi; A P Anselmo; F Beligotti; A Fabbrini; V Santiemma
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Tumor suppressor genes are larger than apoptosis-effector genes and have more regions of active chromatin: Connection to a stochastic paradigm for sequential gene expression programs.

Authors:  Marlene Garcia; James A Mauro; Michael Ramsamooj; George Blanck
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

Review 3.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Rojelio Mejia; Thomas B Nutman
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

4.  Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.

Authors:  H D Foss; M Hummel; S Gottstein; K Ziemann; B Falini; H Herbst; H Stein
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

5.  Hodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal model.

Authors:  Mariko Kawakami; Koji Kawakami; Mitomu Kioi; Pamela Leland; Raj K Puri
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

6.  Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.

Authors:  M Gambacorta; L Flenghi; M Fagioli; S Pileri; L Leoncini; B Bigerna; R Pacini; L N Tanci; L Pasqualucci; S Ascani; A Mencarelli; A Liso; P G Pelicci; B Falini
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

7.  Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density.

Authors:  H D Foss; H Herbst; S Gottstein; G Demel; I Araujó; H Stein
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.

Authors:  Mariko Watanabe; Yuji Ogawa; Kinji Ito; Masaaki Higashihara; Marshall E Kadin; Lawrence J Abraham; Toshiki Watanabe; Ryouichi Horie
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.

Authors:  F Hariri; M Arguello; L Volpon; B Culjkovic-Kraljacic; T H Nielsen; J Hiscott; K K Mann; K L B Borden
Journal:  Leukemia       Date:  2013-03-07       Impact factor: 11.528

Review 10.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.